|
Volumn 249, Issue 3, 2002, Pages 300-304
|
Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia
|
Author keywords
Botulinum toxin; Corticobasal degeneration; Dystonia; Multiple system atrophy; Progressive supranuclear palsy
|
Indexed keywords
BOTULINUM TOXIN A;
ADULT;
AGED;
ANALGESIA;
ARM MOVEMENT;
ARTICLE;
BLEPHAROSPASM;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CONTRACTURE;
CONTROLLED STUDY;
CORTICOBASAL DEGENERATION;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SCREENING;
DYSTONIA;
ELECTROMYOGRAPHY;
FEMALE;
HAND FUNCTION;
HUMAN;
LONG TERM CARE;
MALE;
MORTALITY;
NERVE CELL DEGENERATION;
OUTPATIENT;
PARKINSONISM;
PERSONAL HYGIENE;
PHYSICAL DISABILITY;
PRIORITY JOURNAL;
PROGRESSIVE SUPRANUCLEAR PALSY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-DYSKINESIA AGENTS;
BASAL GANGLIA DISEASES;
BLEPHAROSPASM;
BOTULINUM TOXINS;
DYSTONIA;
ELECTROMYOGRAPHY;
FEMALE;
HUMANS;
MALE;
PARKINSONIAN DISORDERS;
SUPRANUCLEAR PALSY, PROGRESSIVE;
|
EID: 0036192548
PISSN: 03405354
EISSN: None
Source Type: Journal
DOI: 10.1007/s004150200009 Document Type: Article |
Times cited : (65)
|
References (11)
|